Lidds AB
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Intratumoural Injection of a Novel NanoZolid®-Docetaxel Depot Formulation in Patients With Advanced Solid Tumours (NCT04810208) | Lidds AB | 2019-02-28 |
Track Lidds AB automatically
Every clearance here is in the API, with alerts when new ones post.